[1]
Simpson, E., Eichenfield, L., Del Rosso, J., Gooderham, M., Hong, H.C.- ho, Kircik, L., Papp, K., Hebert, A., Krupa, D., Chu, D., Burnett, P., Berk, D. and Higham, R. 2024. Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s372. DOI:https://doi.org/10.25251/skin.8.supp.372.